VRTX vs CRSP
VRTX 与 CRSP 的估值与基本面并排对比(公开数据)。
关键统计
| 指标 | VRTXVERTEX PHARMACEUTICALS INC / MA | CRSPCRISPR THERAPEUTICS AG |
|---|---|---|
| 市值 | $122.73B | $4.59B |
| 市盈率(TTM) | 28.7 | — |
| 市净率 | 6.34 | — |
| 市销率 | 10.2x | 1308.7x |
| 营收 | $12.22B(TTM) | — |
| 营收同比增长 | 8.9% | -90.6% |
| 净利润 | $4.34B(TTM) | — |
| 净利同比增长 | 838.1% | -58.8% |
| 每股收益(稀释) | $16.85(TTM) | — |
| 息税前利润率 | 34.8% | -18933.6% |
| 净资产收益率 | 20.4% | -32.1% |
| 投入资本回报率 | 25.4% | -33.6% |
| 一年总回报 | +3.2% | -19.3% |
数据来自 SEC 文件 · 仅供参考 · 非投资建议
1 万美元的成长:VRTX vs CRSP
| 指标 | VRTX | CRSP |
|---|---|---|
| 期末价值 | $59.1K | $33.8K |
| 总回报 | +490.6% | +238.1% |
| 年化收益 (CAGR) | +19.9% | +13.3% |
| 波动率 | 32.7% | 64.2% |
| 夏普比率 | 0.60 | 0.45 |
| 索提诺比率 | 0.89 | 0.70 |
| 最大回撤 | -41.6% | -85.1% |
基于 2456 个共同交易日,2016-10-19 → 2026-07-29 · 无风险利率 3.83%(当前短端国债,全程恒定)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
相关对比
数据延迟 · 公开数据 · 仅供参考 · 非投资建议(本页不评判孰优孰劣)